Combining with the effect of CONPs on activation of the TRX1-ASK1-JNK apoptotic pathway predominantly in the cancer cells, our results further support the potential anticancer therapeutic applications of CONPs as a novel radiation adjuvant. This evidence concerns the gene MAP3K5 and cancer.